| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MSH5-SAPCD1 readthrough (NMD candidate) | 0.760 | 0.423 |
|
disease | 0.100 | None | 1.000 | 3 | 1 | 2008 | 2012 | |||||||||
|
adaptor related protein complex 3 subunit sigma 2 | 0.931 | 0.115 | 2.3E-05 |
|
disease | 0.440 | None | 1.000 | 3 | 1 | 2011 | 2019 | ||||||||
|
transforming acidic coiled-coil containing protein 3 | 0.615 | 0.615 | 2.7E-07 |
|
disease | 0.470 | None | 1.000 | 3 | 1 | 2010 | 2018 | ||||||||
|
family with sequence similarity 107 member A | 0.674 | 0.462 | 8.3E-07 |
|
disease | 0.100 | None | 1.000 | 3 | 1 | 2010 | 2012 | ||||||||
|
C1q and TNF related 6 | 0.682 | 0.577 | 9.0E-06 |
|
disease | 0.100 | None | 1.000 | 3 | 1 | 2010 | 2016 | ||||||||
|
T cell activation RhoGTPase activating protein | 0.700 | 0.462 | 0.85 |
|
disease | 0.160 | None | 1.000 | 3 | 1 | 2008 | 2019 | ||||||||
|
long intergenic non-protein coding RNA 1620 | 0.805 | 0.269 | 0.45 |
|
disease | 0.100 | None | 1.000 | 3 | 1 | 2009 | 2017 | ||||||||
|
laccase domain containing 1 | 0.700 | 0.423 | 1.2E-05 |
|
disease | 0.170 | None | 1.000 | 3 | 1 | 2008 | 2018 | ||||||||
|
pseudouridine synthase 10 | 0.736 | 0.346 | 7.9E-14 |
|
disease | 0.110 | None | 1.000 | 3 | 1 | 2010 | 2012 | ||||||||
|
C-reactive protein pseudogene 1 |
|
phenotype | 0.100 | None | 1.000 | 3 | 1 | 2012 | 2019 | |||||||||||
|
zinc finger CCCH-type containing 4 | 1.000 | 0.077 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 3 | 1 | 2010 | 2014 | ||||||||
|
zinc finger CCCH-type containing 4 | 1.000 | 0.077 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 3 | 1 | 2010 | 2014 | ||||||||
|
protein tyrosine phosphatase non-receptor type 22 | 0.438 | 0.846 | 3.5E-21 |
|
disease | 0.180 | None | 1.000 | 3 | 1 | 2005 | 2018 | ||||||||
|
major histocompatibility complex, class I, S (pseudogene) | 0.931 | 0.192 |
|
disease | 0.100 | None | 1.000 | 3 | 1 | 2007 | 2011 | |||||||||
|
growth hormone secretagogue receptor | 0.528 | 0.769 | 6.6E-03 |
|
phenotype | 0.100 | None | 1.000 | 3 | 1 | 2010 | 2013 | ||||||||
|
gastric inhibitory polypeptide receptor | 0.670 | 0.538 | 2.0E-29 |
|
phenotype | 0.100 | None | 1.000 | 3 | 1 | 2012 | 2014 | ||||||||
|
gastric inhibitory polypeptide receptor | 0.670 | 0.538 | 2.0E-29 |
|
phenotype | 0.100 | None | 1.000 | 3 | 1 | 2012 | 2014 | ||||||||
|
major histocompatibility complex, class II, DQ alpha 1 | 0.416 | 0.846 | 2.4E-02 |
|
disease | 0.500 | None | 0.931 | 3 | 1 | 1991 | 2016 | ||||||||
|
major histocompatibility complex, class II, DQ alpha 2 | 0.617 | 0.769 | 1.0E-05 |
|
disease | 0.110 | None | 1.000 | 3 | 1 | 2008 | 2016 | ||||||||
|
hepatocyte nuclear factor 4 alpha | 0.461 | 0.808 | 0.15 |
|
phenotype | 0.100 | None | 1.000 | 3 | 1 | 2010 | 2018 | ||||||||
|
haptoglobin-related protein | 0.578 | 0.615 | 5.5E-10 |
|
phenotype | 0.100 | None | 1.000 | 3 | 1 | 2010 | 2019 | ||||||||
|
interleukin 2 receptor subunit alpha | 0.389 | 0.885 | 5.5E-02 |
|
disease | 0.100 | None | 1.000 | 3 | 1 | 2010 | 2016 | ||||||||
|
interleukin 2 receptor subunit beta | 0.491 | 0.846 | 0.29 |
|
disease | 0.140 | None | 1.000 | 3 | 1 | 2010 | 2014 | ||||||||
|
interleukin 13 | 0.386 | 0.846 | 1.4E-02 |
|
disease | 0.700 | None | 0.982 | 3 | 1 | 1995 | 2020 | ||||||||
|
interferon regulatory factor 4 | 0.491 | 0.769 | 0.86 |
|
phenotype | 0.100 | None | 1.000 | 3 | 1 | 2008 | 2018 |